Experts anticipate continued growth in haploidentical transplantation alongside the expansion of advanced immunotherapies such as CAR-T cells, however, regulatory, financial, and infrastructure constraints may delay their widespread implementation, particularly in middle-income settings.
Danielli Oliveira, B. Cabral, Roseli Monteiro et al.· JOURNAL OF BONE MARROW TRANS...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.